Recommended guidelines for the drug treatment of Schizophrenia

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

From Journal of Psychopharmacology

This paper provides recommended guidelines for the pharmacological treatment of schizophrenia. An impressive review of up-to-date evidence based treatment; it offers guidelines that cover the pharmacological management and treatment across the various stages of the illness. Clinical expertise in choosing and managing drug therapy for an individual patient involves an understanding of the research evidence concerning the efficacy, effectiveness and efficiency of the options. It is therefore hoped that the recommendations will help to inform clinical decision making for practitioners, and perhaps also serve as a source of information for patients and carers.   

Abstract

These guidelines from the British Association for Psychopharmacology address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving experts in schizophrenia and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from the participants and interested parties, and cover the pharmacological management and treatment of schizophrenia across the various stages of the illness, including first-episode, relapse prevention, and illness that has proved refractory to standard treatment. The practice recommendations presented are based on the available evidence to date, and seek to clarify which interventions are of proven benefit. It is hoped that the recommendations will help to inform clinical decision making for practitioners, and perhaps also serve as a source of information for patients and carers. They are accompanied by a more detailed qualitative review of the available evidence. The strength of supporting evidence for each recommendation is rated

 

Read this research for free

Article details
Barnes, T., & , . (2011). Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology Journal of Psychopharmacology, 25 (5), 567-620 DOI: 10.1177/0269881110391123

     
This entry was posted in Medicine, SAGE Insight and tagged , , , , . Bookmark the permalink.